JP2013515486A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515486A5 JP2013515486A5 JP2012546229A JP2012546229A JP2013515486A5 JP 2013515486 A5 JP2013515486 A5 JP 2013515486A5 JP 2012546229 A JP2012546229 A JP 2012546229A JP 2012546229 A JP2012546229 A JP 2012546229A JP 2013515486 A5 JP2013515486 A5 JP 2013515486A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- binding fragment
- ser
- gly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29009209P | 2009-12-24 | 2009-12-24 | |
| US61/290,092 | 2009-12-24 | ||
| US30635910P | 2010-02-19 | 2010-02-19 | |
| US61/306,359 | 2010-02-19 | ||
| US32831610P | 2010-04-27 | 2010-04-27 | |
| US61/328,316 | 2010-04-27 | ||
| US34927310P | 2010-05-28 | 2010-05-28 | |
| US61/349,273 | 2010-05-28 | ||
| US35612610P | 2010-06-18 | 2010-06-18 | |
| US61/356,126 | 2010-06-18 | ||
| PCT/US2010/061987 WO2011079257A2 (en) | 2009-12-24 | 2010-12-23 | Human antibodies to human angiopoietin-like protein 4 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015096446A Division JP2015145424A (ja) | 2009-12-24 | 2015-05-11 | ヒトアンギオポエチン様タンパク質４に対するヒト抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013515486A JP2013515486A (ja) | 2013-05-09 |
| JP2013515486A5 true JP2013515486A5 (cg-RX-API-DMAC7.html) | 2014-02-06 |
| JP6000855B2 JP6000855B2 (ja) | 2016-10-05 |
Family
ID=43629324
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012546229A Expired - Fee Related JP6000855B2 (ja) | 2009-12-24 | 2010-12-23 | ヒトアンギオポエチン様タンパク質４に対するヒト抗体 |
| JP2015096446A Pending JP2015145424A (ja) | 2009-12-24 | 2015-05-11 | ヒトアンギオポエチン様タンパク質４に対するヒト抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015096446A Pending JP2015145424A (ja) | 2009-12-24 | 2015-05-11 | ヒトアンギオポエチン様タンパク質４に対するヒト抗体 |
Country Status (30)
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3672B1 (ar) | 2008-12-15 | 2020-08-27 | Regeneron Pharma | أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9). |
| AR084938A1 (es) | 2011-01-28 | 2013-07-10 | Sanofi Sa | Anticuerpos humanos contra la proproteina convertasa subtilisina/kexina tipo 9 (anti pcsk9) para usar en metodos para tratar grupos de pacientes |
| AR087305A1 (es) | 2011-07-28 | 2014-03-12 | Regeneron Pharma | Formulaciones estabilizadas que contienen anticuerpos anti-pcsk9, metodo de preparacion y kit |
| EP2758535B1 (en) * | 2011-09-19 | 2016-11-09 | Kymab Limited | Antibodies, variable domains&chains tailored for human use |
| AU2013245630A1 (en) * | 2012-04-13 | 2014-10-30 | The Johns Hopkins University | Treatment of ischemic retinopathies |
| US9255154B2 (en) | 2012-05-08 | 2016-02-09 | Alderbio Holdings, Llc | Anti-PCSK9 antibodies and use thereof |
| TW201823460A (zh) | 2012-05-29 | 2018-07-01 | 美商再生元醫藥公司 | 生產細胞株增強子 |
| KR20150041662A (ko) | 2012-08-13 | 2015-04-16 | 리제너론 파아마슈티컬스, 인크. | Ｐｈ-의존적 결합 특성을 갖는 항-ｐｃｓｋ9 항체 |
| GB201301313D0 (en) * | 2013-01-25 | 2013-03-06 | Univ Singapore | Respiratory Tract Infections |
| MX2015016978A (es) * | 2013-06-10 | 2016-04-25 | Merck Sharp & Dohme | Proteinas de union a antigeno neutralizantes de citomegalovirus. |
| KR101538787B1 (ko) * | 2013-06-27 | 2015-07-22 | 인하대학교 산학협력단 | 췌장염 진단용 바이오 마커 조성물 |
| DK3092491T3 (en) * | 2014-01-07 | 2019-02-11 | Bioatla Llc | Proteins that are targeted orthologs |
| AP2017009721A0 (en) * | 2014-08-07 | 2017-01-31 | Novartis Ag | Angiopoietin-like 4 antibodies and methods of use |
| EP3194437B1 (en) | 2014-08-07 | 2021-01-20 | Novartis AG | Angiopoietin-like 4 (angptl4) antibodies and methods of use |
| US9556225B2 (en) * | 2014-10-15 | 2017-01-31 | Uniao Quimica Farmaceutica Nacional S/A | Peptide stimulator of cell survival and proliferation |
| WO2016181409A1 (en) | 2015-05-11 | 2016-11-17 | Cadila Healthcare Limited | Saroglitazar magnesium for the treatment of chylomicronemia syndrome - |
| WO2017011929A1 (zh) * | 2015-07-17 | 2017-01-26 | 北京大学第一医院 | 检测血清血管生成素样蛋白2含量的物质在制备检测肝脏炎症和纤维化程度产品中的应用 |
| TW201713690A (zh) | 2015-08-07 | 2017-04-16 | 再生元醫藥公司 | 抗ａｎｇｐｔｌ８抗體及其用途 |
| EA201890519A1 (ru) | 2015-08-18 | 2018-07-31 | Ридженерон Фармасьютикалз, Инк. | Ингибирующие антитела против pcsk9 для лечения пациентов с гиперлипидемией, подвергающихся аферезу липопротеинов |
| WO2017064635A2 (en) | 2015-10-14 | 2017-04-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
| EP3541839A1 (en) | 2016-11-17 | 2019-09-25 | Regeneron Pharmaceuticals, Inc. | Methods of treating obesity with anti-angptl8 antibodies |
| US11046764B2 (en) | 2017-01-03 | 2021-06-29 | Trellis Bioscience, Llc | Native human antibodies for immune checkpoint modulation targets TIM-3 and B7-H3 |
| US20190031774A1 (en) | 2017-06-09 | 2019-01-31 | Sanofi Biotechnology | Methods for treating hyperlipidemia in diabetic patients by administering a pcsk9 inhibitor |
| EP3938405A4 (en) * | 2019-03-20 | 2022-12-28 | Javelin Oncology, Inc. | ANTI-ADAM12 ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AND COMPOSITIONS AND METHODS COMPRISING THEM |
| WO2021037007A1 (zh) | 2019-08-29 | 2021-03-04 | 荣昌生物制药(烟台)股份有限公司 | 抗pd-l1抗体及其应用 |
| WO2021119019A1 (en) * | 2019-12-09 | 2021-06-17 | Empirico Inc. | Oligonucleotides for treatment of angiopoietin like 4 (angptl4) related diseases |
| HUE062777T2 (hu) | 2020-02-26 | 2023-12-28 | Vir Biotechnology Inc | SARS-CoV-2 elleni antitestek |
| WO2022006555A2 (en) * | 2020-07-02 | 2022-01-06 | Gigagen, Inc. | BISPECIFIC ANTIGEN BINDING PROTEINS TARGETING PD-L1 AND TGF-β AND METHODS OF USE |
| TW202218682A (zh) * | 2020-07-02 | 2022-05-16 | 美商瑪柏里提克斯公司 | 細胞結合蛋白及使用方法 |
| WO2023239307A1 (en) * | 2022-06-10 | 2023-12-14 | Nanyang Technological University | Methods of treating liver fibrosis, inflammation or associated diseases using an angptl4 antagonist |
| PE20251067A1 (es) * | 2022-08-02 | 2025-04-09 | Nona Biosciences Suzhou Co Ltd | Conjugado anticuerpo-farmaco msln |
| CN117535353A (zh) * | 2023-10-11 | 2024-02-09 | 首都医科大学附属北京潞河医院 | 一种糖尿病视网膜病变模型的建立方法及应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7070959B1 (en) | 1999-06-08 | 2006-07-04 | Regeneron Pharmaceuticals, Inc. | Modified chimeric polypeptides with improved pharmacokinetic properties |
| US20040101920A1 (en) | 2002-11-01 | 2004-05-27 | Czeslaw Radziejewski | Modification assisted profiling (MAP) methodology |
| EP1740946B1 (en) | 2004-04-20 | 2013-11-06 | Genmab A/S | Human monoclonal antibodies against cd20 |
| WO2006068953A2 (en) * | 2004-12-21 | 2006-06-29 | Astrazeneca Ab | Antibodies directed to angiopoietin-2 and uses thereof |
| AU2006204001B2 (en) | 2005-01-07 | 2011-06-16 | Lexicon Pharmaceuticals, Inc. | Monoclonal antibodies against angiopoietin-like protein 4 (ANGPTL4 ) |
| PL1962895T3 (pl) | 2005-12-16 | 2013-06-28 | Regeneron Pharma | Terapeutyczne zastosowanie antagonisty dii4 oraz inhibitora vegf do inhibicji wzrostu nowotworów |
| AU2007227251A1 (en) * | 2006-03-20 | 2007-09-27 | Amgen Fremont, Inc. | Antibodies directed to angiopoietin-like protein 4 and uses thereof |
| MY159787A (en) | 2006-06-02 | 2017-01-31 | Regeneron Pharma | High affinity antibodies to human il-6 receptor |
| NO347649B1 (no) | 2006-12-14 | 2024-02-12 | Regeneron Pharma | Humant antistoff eller antistoff fragment som spesifikt binder human deltaliknende ligand 4 (hDII4), nukleinsyremolekyl som koder for slike og vektor og vert-vektorsystemer, samt fremgangsmåte for fremstilling, sammensetning og anvendelse. |
| JO3672B1 (ar) | 2008-12-15 | 2020-08-27 | Regeneron Pharma | أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9). |
-
2010
- 2010-12-16 JO JOP/2010/0453A patent/JO3274B1/ar active
- 2010-12-22 UY UY0001033144A patent/UY33144A/es unknown
- 2010-12-22 AR ARP100104893A patent/AR079708A1/es unknown
- 2010-12-23 SI SI201031459A patent/SI2516466T1/sl unknown
- 2010-12-23 SM SM20170280T patent/SMT201700280T1/it unknown
- 2010-12-23 AU AU2010336369A patent/AU2010336369C1/en not_active Ceased
- 2010-12-23 LT LTEP10798240.7T patent/LT2516466T/lt unknown
- 2010-12-23 US US12/977,361 patent/US8354103B2/en active Active
- 2010-12-23 TW TW099145406A patent/TWI488643B/zh not_active IP Right Cessation
- 2010-12-23 SG SG2012044871A patent/SG181784A1/en unknown
- 2010-12-23 KR KR1020127019046A patent/KR101842570B1/ko not_active Expired - Fee Related
- 2010-12-23 JP JP2012546229A patent/JP6000855B2/ja not_active Expired - Fee Related
- 2010-12-23 PL PL10798240T patent/PL2516466T3/pl unknown
- 2010-12-23 BR BR112012017765A patent/BR112012017765A2/pt not_active Application Discontinuation
- 2010-12-23 HR HRP20170524TT patent/HRP20170524T1/hr unknown
- 2010-12-23 ES ES10798240.7T patent/ES2628135T3/es active Active
- 2010-12-23 PT PT107982407T patent/PT2516466T/pt unknown
- 2010-12-23 RS RS20170522A patent/RS56009B1/sr unknown
- 2010-12-23 WO PCT/US2010/061987 patent/WO2011079257A2/en not_active Ceased
- 2010-12-23 RU RU2012131547/10A patent/RU2580045C2/ru not_active IP Right Cessation
- 2010-12-23 NZ NZ600768A patent/NZ600768A/en not_active IP Right Cessation
- 2010-12-23 EP EP10798240.7A patent/EP2516466B1/en active Active
- 2010-12-23 MX MX2012007460A patent/MX337082B/es active IP Right Grant
- 2010-12-23 CN CN2010800628627A patent/CN102741284A/zh active Pending
- 2010-12-23 CA CA2785158A patent/CA2785158C/en active Active
- 2010-12-23 DK DK10798240.7T patent/DK2516466T3/en active
- 2010-12-23 HU HUE10798240A patent/HUE034722T2/en unknown
-
2012
- 2012-06-14 IL IL220402A patent/IL220402A/en not_active IP Right Cessation
- 2012-06-19 ZA ZA2012/04507A patent/ZA201204507B/en unknown
- 2012-12-12 US US13/712,268 patent/US9120851B2/en active Active
-
2015
- 2015-05-11 JP JP2015096446A patent/JP2015145424A/ja active Pending
-
2017
- 2017-05-17 CY CY20171100521T patent/CY1118898T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013515486A5 (cg-RX-API-DMAC7.html) | ||
| RU2012131547A (ru) | Антитела человека против ангиопоэтин-подобного белка 4 человека | |
| US11542325B2 (en) | Anti-activin A antibodies and uses thereof | |
| RU2013155906A (ru) | Антитела анти-angptl3 и их применение | |
| US10561653B2 (en) | 5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer | |
| CA2698382C (en) | Antigen binding proteins capable of binding thymic stromal lymphopoietin | |
| US20160032014A1 (en) | Human antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9 | |
| RU2012156938A (ru) | Антитела против gdf8 человека | |
| RU2011129316A (ru) | Высокоаффинные человеческие антитела к pcsk9 | |
| JP2013542194A5 (cg-RX-API-DMAC7.html) | ||
| JP7292526B2 (ja) | 操作された抗ｉｌ－２抗体 | |
| JP2018510617A5 (cg-RX-API-DMAC7.html) | ||
| WO2014150983A2 (en) | Human antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9 | |
| JP2016501892A5 (cg-RX-API-DMAC7.html) | ||
| JP2015503909A5 (cg-RX-API-DMAC7.html) | ||
| RU2016122340A (ru) | Il-17a-связующий агент и способы его применения | |
| RU2019139093A (ru) | Фармацевтическая композиция на основе антитела к pd-l1 и ее применение | |
| JP6949012B2 (ja) | Ｂ型肝炎表面抗原に対する抗体及びその使用 | |
| JP2019162119A5 (cg-RX-API-DMAC7.html) | ||
| CN111094339A (zh) | 抗pd-1抗体和抗lag-3抗体联合在制备治疗肿瘤的药物中的用途 | |
| WO2014072741A1 (en) | Humanised antibody and method of production thereof | |
| EP3145544A1 (en) | Ang2 antibodies | |
| CA2824313A1 (en) | Tlr3 binding agents | |
| CN111808196B (zh) | 抗pd-1抗体及其用途 | |
| EP3532501A1 (en) | Anti-rankl antibodies and uses thereof |